Global markets slammed by Moderna's Omicron vaccine warning

The markets selloff accelerated as data showed eurozone inflation rocketed on runaway energy prices to a record 4.9%.

A healthcare worker fills a syringe with the Moderna COVID-19 vaccine at the East Boston Neighborhood Health Center in Boston, Massachusetts, in the United States on 24 December 2020. Picture: AFP.

LONDON - World stocks slid on Tuesday after Moderna warned current vaccines might be less effective at fending off the Omicron variant, and after eurozone inflation spiked to a record high.

Frankfurt, London, and Paris followed Asia sharply lower before limiting losses to around half of one percent, with sentiment dogged by fears of fresh economic fallout from the long-running COVID crisis.

Wall Street followed the lead as the Dow was off almost one percent after the opening bell while the tech-heavy Nasdaq was down 0.4%.

Oil prices took a tumble following the Moderna remarks, which have reignited stubborn concerns over how the Omicron variant spread could hit energy demand.

The markets selloff accelerated as data showed eurozone inflation rocketed on runaway energy prices to a record 4.9%.

'MARKETS HATE UNCERTAINTY'

"It only took one comment from the boss of drugs firm Moderna to derail markets once again," noted AJ Bell investment director Russ Mould.

"Markets hate uncertainty, and this is precisely what we have now. No-one knows how much trouble the new variant is going to cause."

Moderna chief executive Stephane Bancel's comments, in an interview with the Financial Times, sent traders running for cover.

"There is no world, I think, where (the effectiveness) is the same level ... we had with Delta," Bancel told the newspaper.

The high amount of mutations on Omicron and its swift spread in South Africa indicated the present jabs would need to be tweaked, he indicated.

In foreign exchange, the euro rose Tuesday as data showed inflation in the 19-nation single-currency area soared in November to more than double the European Central Bank's 2.0% target.

Sky-high inflation has placed intense pressure on the ECB and the US Federal Reserve to rein in vast stimulus programmes - with traders also fearing premature interest rate hikes to tame prices.

However, the emergence this week of the Omicron mutant coronavirus strain has complicated the picture.

'INFLATION DRUMBEAT CONTINUES'

"The inflation drumbeat continues to sound, providing another reason to worry for beleaguered investors," said IG analyst Chris Beauchamp.

"With central banks having done their utmost in the previous part of this (Covid) crisis, there is fear that they will be less able to act this time, and indeed may still continue on a tightening path."

Later on Tuesday, markets will digest key testimony from US Treasury Secretary Janet Yellen and Federal Reserve chair Jay Powell.

"All eyes are again on US fiscal and monetary policy and if either official needed an excuse to continue to leave policy ultra-loose then the latest variant of the COVID-19 virus is surely it," added Mould at AJ Bell.

In Britain, meanwhile, traders are also reassessing hopes of a pre-Christmas interest rate hike.

Prior to Omicron, the Bank of England had been forecast to lift rates to dampen near decade-high UK inflation.

"Hopes are fading that the Bank of England will raise interest rates later this month," noted Hargreaves Lansdown analyst Susannah Streeter, citing the uncertain impact of the new variant.